Abvc biopharma reports third quarter 2023 financial and operational results

Fremont, ca, nov. 15, 2023 (globe newswire) -- via newmediawire  – abvc biopharma, inc. (nasdaq: abvc) ("company"): today, a biotechnology company specializing in botanically based solutions that deliver high efficacy and low toxicity to improve health outcomes announced its financial and operating results for the third quarter of 2023. these results, including the financial statements included herein, can be found in the company's quarterly report on form 10-q that was filed earlier today with the securities and exchange commission
ABVC Ratings Summary
ABVC Quant Ranking